A Retrospective Analysis of Pancreatic Injuries and Treatment Outcomes
Launched by KERN MEDICAL CENTER · Jan 25, 2024
Trial Information
Current as of June 30, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Hospitalized at Kern Medical Center after presenting to the institution's emergency department as a tier 1 and 2 trauma activation
- • Hospitalized following blunt or penetrating abdominal injury
- • Diagnosed with traumatic pancreatic injury during same admission
- Exclusion Criteria:
- • history of pancreatic surgery
- • Iatrogenic pancreatic injuries
About Kern Medical Center
Kern Medical Center is a leading healthcare institution dedicated to providing high-quality medical care and advancing clinical research. With a commitment to innovation and excellence, the center actively participates in clinical trials aimed at improving patient outcomes and exploring new therapeutic options. Kern Medical Center's robust infrastructure and interdisciplinary team of experienced professionals facilitate the efficient execution of diverse clinical studies, ensuring adherence to the highest ethical standards and regulatory guidelines. The center's focus on collaboration and patient-centered care makes it a pivotal player in the advancement of medical science and the enhancement of community health.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Bakersfield, California, United States
Patients applied
Trial Officials
Amber Jones, DO, MPH
Principal Investigator
Kern Medical Center
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported